Nascent Biotech Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q2 2022 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Nascent Biotech Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q2 2022 to Q2 2024.
- Nascent Biotech Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending June 30, 2024 was $0.000.
- Nascent Biotech Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $0.000, a 100% decline from 2022.
- Nascent Biotech Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $11.1K, a 62.9% decline from 2021.
- Nascent Biotech Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $30K.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)